Clinical Trials Logo

Filter by:
NCT ID: NCT00641537 Completed - Clinical trials for Relapsing-Remitting Multiple Sclerosis

CLARITY Extension Study

Start date: February 29, 2008
Phase: Phase 3
Study type: Interventional

The purpose of this extension trial was to further evaluate the safety and tolerability of oral cladribine in subjects who have previously completed treatment within Trial 25643 (CLARITY). This trial also explored clinical benefit of prolonged 192-week versus 96-week treatment.

NCT ID: NCT00641056 Completed - Clinical trials for Type 2 Diabetes Mellitus

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

Start date: April 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the effects of 2.0 mg exenatide once weekly and insulin glargine, titrated to glucose targets using the algorithm described by Yki- Järvinen et al.(2007), with respect to glycemic improvements, body weight, fasting lipids, safety, and tolerability.

NCT ID: NCT00639821 Completed - Clinical trials for Inflammatory Bowel Diseases

Mucosal Gene Expression Defects in IBD

Start date: July 2004
Phase: N/A
Study type: Observational

This study investigated the mucosal gene expression defects associated with active Crohn's disease (CD)and ulcerative colitis (UC), and studied the effect of infliximab induced downregulation of inflammation and mucosal healing on these abnormalities, using whole genome gene expression microarrays.

NCT ID: NCT00639743 Completed - Pulmonary Embolism Clinical Trials

PEITHO Pulmonary Embolism Thrombolysis Study

PEITHO
Start date: November 16, 2007
Phase: Phase 3
Study type: Interventional

Heparin is the reference therapy for most patients with pulmonary embolism. Some patients with sub-massive pulmonary embolism defined by normal blood pressure and dysfunction of the right ventricle have a higher mortality risk. It has been suggested that thrombolytic treatment, a drug that dissolves blood clots more rapidly, may reduce the mortality in those patients. The studies reported to date were unable to confirm or refute this hypothesis because the number of patients included in those studies is too low. The aim of the study is to compare thrombolytic treatment with heparin (which is the reference therapy for pulmonary embolism) in a large group of patients with sub-massive pulmonary embolism.

NCT ID: NCT00639496 Completed - Pulmonary Fibrosis Clinical Trials

Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)

IFIGENIA
Start date: March 2000
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether NAC added to prednisone, and azathioprine has a better effect on lung function, radiology and clinical condition than placebo + prednisone in combination with azathioprine after 6 and 12 months.

NCT ID: NCT00638690 Completed - Prostatic Neoplasms Clinical Trials

Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Start date: May 2008
Phase: Phase 3
Study type: Interventional

This is a phase 3 study to compare the clinical benefit of abiraterone acetate plus prednisone with placebo plus prednisone in patients with metastatic castration-resistant prostate cancer (CRPC) who have failed one or two chemotherapy regimens. At least one of the previous chemotherapies must have contained docetaxel.

NCT ID: NCT00638001 Completed - Haemophilia A Clinical Trials

Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy

Start date: March 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study intend to evaluate the effectiveness of functional orthoses (including custom-made insoles and shoes) for preventing and controlling repetitive haemarthrosis in patients suffering of haemophilic ankle arthropathy, as well as the orthoses' impact on foot health-related quality of life.

NCT ID: NCT00637754 Completed - Heart Arrhythmias Clinical Trials

Safety of Sports for Patients With Implantable Cardioverter-Defibrillators

Start date: September 2006
Phase: N/A
Study type: Observational

The registry will obtain information to determine the safety of sports participation for patients with defibrillators (ICDs).

NCT ID: NCT00637741 Completed - Clinical trials for Critical Limb Ischemia

DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions

Start date: March 2008
Phase: Phase 4
Study type: Interventional

The objective of this clinical investigation is to evaluate the long-term (up to 12 months) outcome of the 200 mm long self-expanding nitinol EverFlex (ev3) stent in long femoropopliteal lesions (TASC C & D) Is is the first time that the use of 200 mm long stents will be evaluated in these lesions. It is expected that the outcome of the treatment with this type of long stents will be better as the treatment of identical lesions lengths with multiple shorter stents.

NCT ID: NCT00637377 Completed - Clinical trials for Macular Degeneration

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)

VIEW 2
Start date: April 2008
Phase: Phase 3
Study type: Interventional

This study is a phase III, double-masked, randomized, study of the efficacy and safety of VEGF Trap-Eye in patients with neovascular age-related macular degeneration. Approximately 1200 patients will be randomized in Europe, Asia, Japan, Australia and South America.